In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2

Drug & therapy

GLP-1 & obesity drugs

Semaglutide, tirzepatide and the race for weight-loss medicines.

Now

Approvals & regulatory · 6h ago

FDA slams GLP-1 compounder over risk of contaminating drugs ‘with filth’

1 outlet GLP-1 & obesity drugs Eli Lilly FDA

Approvals & regulatory · yesterday

FDA Warns Pharmacy About Illegal GLP-1 Compounding

1 outlet GLP-1 & obesity drugs FDA